Free Trial

Enveric Biosciences (ENVB) Earnings Date, Estimates & Call Transcripts

$0.82
+0.00 (+0.40%)
(As of 05/24/2024 03:59 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 12Estimated
Actual EPS
(Mar. 25)
-$1.46 Beat By $0.09
Consensus EPS
(Mar. 25)
-$1.55
Skip Charts & View Estimated and Actual Earnings Data

ENVB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENVB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enveric Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251($0.40)($0.40)($0.40)
Q2 20251($0.35)($0.35)($0.35)
Q3 20251($0.35)($0.35)($0.35)
Q4 20251($0.31)($0.31)($0.31)
FY 20254($1.41)($1.41)($1.41)

ENVB Earnings Date and Information

Enveric Biosciences last issued its quarterly earnings data on March 25th, 2024. The reported ($1.46) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.55) by $0.09. Enveric Biosciences has generated ($6.41) earnings per share over the last year (($6.41) diluted earnings per share). Earnings for Enveric Biosciences are expected to grow in the coming year, from ($1.98) to ($1.02) per share. Enveric Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.

Enveric Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2024
(Estimated)
------- 
3/25/2024Q4 2023($1.55)($1.46)+$0.09($1.46)--
11/13/2023Q3 2023($1.93)($1.30)+$0.63($1.30)--
8/14/2023Q2 2023-($3.04)($3.04)($3.04)--
5/15/2023Q1 2023-($2.22)($2.22)($2.13)--
4/3/2023Q4 2022-($0.75)($0.75)$3.39--
11/14/2022Q3 2022-($1.46)($1.46)($1.46)--
8/12/2022Q2 2022-($2.73)($2.73)($2.73)--
5/13/2022Q1 2022-($5.50)($5.50)($0.11)--
3/31/2022Q4 2021-($7.00)($7.00)$1.45--
5/18/2021Q1 2021-($10.00)($10.00)($0.20)--
11/16/2020Q3 2020-($40.00)($40.00)($0.80)-$8.48 million
8/14/2020Q2 2020-($96.00)($96.00)($1.92)-$8.26 million
5/15/2020Q1 2020-($120.00)($120.00)($2.40)-$9.60 million
8/14/2019Q2 2019-($150.00)($150.00)($3.00)-$11.02 million

Enveric Biosciences Earnings - Frequently Asked Questions

When is Enveric Biosciences's earnings date?

Enveric Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on ENVB's earnings history.

Did Enveric Biosciences beat their earnings estimates last quarter?

In the previous quarter, Enveric Biosciences (NASDAQ:ENVB) reported ($1.46) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.55) by $0.09. Learn more on analysts' earnings estimate vs. ENVB's actual earnings.

How much profit does Enveric Biosciences generate each year?

Enveric Biosciences (NASDAQ:ENVB) has a recorded net income of -$17.29 million. ENVB has generated -$6.41 earnings per share over the last four quarters.

What is Enveric Biosciences's EPS forecast for next year?

Enveric Biosciences's earnings are expected to grow from ($1.98) per share to ($1.02) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ENVB) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners